Drugs / TERIPARATIDE
last change Dec 2025 re-read 9 days ago

TERIPARATIDE

Protein / enzyme biologic targets PTH1R via activation

Developed for
osteoporosis
Investigated by
Azelon Pharmaceuticals

Trials 1

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01604057 Nov 2011 → Jul 2012 osteoporosis Azelon Pharmaceuticals Unknown No outcome recorded

Press releases naming this drug 20 releases

DateIssuerRelease
2025-12-15 Amphastar Pharmaceuticals, Inc. Amphastar Announces FDA Approval for Teriparatide Injection amphastar.com ↗
2023-11-17 Teva Branded Pharmaceutical Products R&D, Inc. Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S. tevapharm.com ↗
2023-11-09 Entera Bio Ltd. Entera Bio Reports Key Milestone Relating to Oral PTH (1-34) Peptide (EB613) Phase 3 Program: ASBMR-SABRE Has Submitted to FDA the Full Qualification Plan to Approve BMD as a Surrogate Endpoint for Osteoporosis enterabio.com ↗
2022-11-14 Halcygen Pharmaceuticals Limited Stelis receives a positive recommendation from European Medicines Agency (EMA) granting market authorization for KaulivTM, a recombinant human teriparatide biosimilar to treat osteoporosis strides.com ↗
2022-02-20 MinaPharm Pharmaceuticals Minapharm Pharmaceuticals Announces the Successful Completion of its Phase 1 Clinical Trial in Europe for its Recombinant Teriparatide, Bonosome. minapharm.com ↗
2019-10-21 Alvogen Korea Alvogen announces exclusive commercialization agreements in South Korea, Israel and Canada for Teriparatide (PF708) alvogen.com ↗
2017-11-09 Eli Lilly and Company New Data on FORTEO® (teriparatide [rDNA origin] injection) Showed Reduced Risk for New Vertebral and Clinical Fractures in Postmenopausal Women with Severe Osteoporosis lilly.com ↗
2013-05-29 Eli Lilly and Company New Data on FORTEO® (teriparatide [rDNA origin] injection) Show Increased Bone Mineral Density in Men with Glucocorticoid-Induced Osteoporosis lilly.com ↗
2012-10-15 Eli Lilly and Company Lilly Announces New Data Further Exploring Mechanistic Differences Between FORTEO® (teriparatide [rDNA origin] injection) and Zoledronic Acid lilly.com ↗
2011-09-19 Eli Lilly and Company Research Suggests FORTEO® Significantly Increases Bone Strength lilly.com ↗
2011-09-19 Eli Lilly and Company New Data Explore Mechanistic Differences Between FORTEO® and Zoledronic Acid lilly.com ↗
2011-03-17 Eli Lilly and Company Lilly Announces Important Action Regarding Recall of Alcohol Prep Pads Made by Triad Group Included in Forteo Starter Kits lilly.com ↗

Evidence & citations 24 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as TERIPARATIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as (1-34)-human parathyroid hormone ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as 1-34-human pth ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as Bonsity ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as Forsteo ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as Forteo ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as Human parathyroid hormone 1-34 ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as Kauliv ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as Livogiva ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as LY 333334 ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as Movymia ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as Pth (1-34) ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as Qutavina ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as Sondelbay ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as Teriparatida ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as Teriparatide rdna ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as Teriparatide recombinant human ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as Teriparatide sun ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as Terrosa ChEMBL registry synonym — accepted as the source's own label CHEMBL525610 ↗
Known as ZT-034 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01604057 ↗
Action Activate “Parathyroid hormone receptor agonist” CHEMBL525610 ↗
Modality Protein / enzyme biologic — CHEMBL525610 ↗
Route Intranasal “Nasal Spray” NCT01604057 ↗
Target PTH1R “Parathyroid hormone receptor agonist” CHEMBL525610 ↗